Sands Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $375M | Sell |
|
|||||
|
2019
Q2 | $491M | Sell |
|
|||||
|
2019
Q1 | $522M | Sell |
|
|||||
|
2018
Q4 | $520M | Sell |
|
|||||
|
2018
Q3 | $625M | Sell |
|
|||||
|
2018
Q2 | $653M | Sell |
|
|||||
|
2018
Q1 | $588M | Sell |
|
|||||
|
2017
Q4 | $689M | Sell |
|
|||||
|
2017
Q3 | $750M | Sell |
|
|||||
|
2017
Q2 | $772M | Sell |
|
|||||
|
2017
Q1 | $788M | Sell |
|
|||||
|
2016
Q4 | $777M | Sell |
|
|||||
|
2016
Q3 | $946M | Sell |
|
|||||
|
2016
Q2 | $849M | Sell |
|
|||||
|
2016
Q1 | $954M | Sell |
|
|||||
|
2015
Q4 | $1.22B | Buy |
|
|||||
|
2015
Q3 | $1.2B | Sell |
|
|||||
|
2015
Q2 | $1.59B | Sell |
|
|||||
|
2015
Q1 | $1.54B | Buy |
|
|||||
|
2014
Q4 | $1.1B | Buy |
|
|||||
|
2014
Q3 | $873M | Buy |
|
|||||
|
2014
Q2 | $742M | Buy |
|
|||||
|
2014
Q1 | $664M | Sell |
|
|||||
|
2013
Q4 | $720M | Sell |
|
|||||
|
2013
Q3 | $741M | Sell |
|
|||||
|
2013
Q2 | $632M | Buy |
|